SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012949
Filing Date
2020-11-05
Accepted
2020-11-05 17:20:09
Documents
54
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20200930x10q.htm   iXBRL 10-Q 1805073
2 EX-10.3 axsm-20200930xex10d3.htm EX-10.3 766057
3 EX-10.4 axsm-20200930xex10d4.htm EX-10.4 142965
4 EX-10.5 axsm-20200930xex10d5.htm EX-10.5 90507
5 EX-31.1 axsm-20200930xex31d1.htm EX-31.1 10884
6 EX-31.2 axsm-20200930xex31d2.htm EX-31.2 10186
7 EX-32.1 axsm-20200930xex32d1.htm EX-32.1 5065
8 EX-32.2 axsm-20200930xex32d2.htm EX-32.2 5044
  Complete submission text file 0001558370-20-012949.txt   6921468

Data Files

Seq Description Document Type Size
9 EX-101.SCH axsm-20200930.xsd EX-101.SCH 42197
10 EX-101.CAL axsm-20200930_cal.xml EX-101.CAL 30427
11 EX-101.DEF axsm-20200930_def.xml EX-101.DEF 112306
12 EX-101.LAB axsm-20200930_lab.xml EX-101.LAB 397941
13 EX-101.PRE axsm-20200930_pre.xml EX-101.PRE 261582
14 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20200930x10q_htm.xml XML 803047
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 201291601
SIC: 2834 Pharmaceutical Preparations